Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
about
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competenceThe management of infertility associated with polycystic ovary syndromePotential action of androstenedione on the proliferation and apoptosis of stromal endometrial cellsGenetic, hormonal and metabolic aspects of PCOS: an updateStrategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientistsEffect of urinary bisphenolA on androgenic hormones and insulin resistance in preadolescent girls: a pilot study from the Ewha Birth & Growth CohortTranscriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Late pregnancy complications in polycystic ovarian syndromeA retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndromeSerum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome.Statins in the treatment of polycystic ovary syndrome.Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.Altered theca and cumulus oocyte complex gene expression, follicular arrest and reduced fertility in cows with dominant follicle follicular fluid androgen excess.Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study.Insulin resistance and fertility in polycystic ovary syndromeBiology of obesity: lessons from animal models of obesityEffect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat modelOriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in ratsAssociation of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome.Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass indexThe impact of obesity on egg qualityThe effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms.The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndromeOvarian hypertension: polycystic ovary syndrome.The Effect of Exercise in PCOS Women Who Exercise Regularly.The use and misuse of matching in case-control studies: the example of polycystic ovary syndrome.Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome.Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare.Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women.Ovarian and adrenal hyperandrogenism.Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistancePancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metforminTherapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndromeThe association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome.Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndromeAnterior Segment Findings in Women with Polycystic Ovary SyndromeHeart rate variability and heart rate turbulence in patients with polycystic ovary syndrome.Exercise therapy in polycystic ovary syndrome: a systematic review.
P2860
Q24629523-0A17E622-BF3F-44B8-9431-C6679E6F400BQ24798425-F710CE34-2CD2-4AC5-BD88-CC7C69F02BE8Q24801856-21A410E0-2763-409E-999B-355B7757F453Q26740034-CE577507-30B6-4AAA-A558-B10D94BD6EC7Q26749044-C8190432-2EBC-4C7D-AC56-9433396275E7Q28392952-AC9FFCB9-7564-45A7-8660-58BD1EBCD7FAQ33399651-FD6B8E38-D542-4C7B-AAF6-85400D437F2BQ33569169-AD8653AE-F96A-448E-A158-237D79989A67Q33598516-2B5731E2-32F8-4C29-AD4C-2CCE3DC888EEQ33614259-BFF37B85-E33D-4F32-BB17-1019F991FA3DQ33750620-76EE41FD-3721-4EDA-8CCE-AD0FBDE70DEFQ33789151-0FE79C9B-343A-42D2-94E7-C663EE62C927Q33905613-0107FF48-A1C9-4841-8618-B9118586B13DQ34352197-F67838B7-AD6B-463E-92A2-3613C8E0D0BBQ34393333-1D20B98A-81DD-49EB-B933-2E47A4A7DFD8Q34480793-66F3DF32-3EC1-45F1-9042-9760B19442B0Q34497095-82730CED-2E1B-41C4-AEAD-E0F4D23992B9Q35051785-49FBF2E3-4828-4618-9CBA-341EFAE6594EQ35092640-33175DCA-3FF3-4B53-9F35-56E0712B8F67Q35114712-DB24E9BF-21FB-4B18-B0FD-717AFC617B08Q35140103-8A0E16A1-F9AB-4DDA-9B2F-A1FB502B8EE7Q35171112-8BB99501-67D3-477D-8498-F0390A0DCFB2Q35181929-6960B2F6-7404-4C4F-8716-116A7088AC87Q35349649-6D616996-32B5-4D36-991B-064383D17CDEQ35415958-7C85C67D-438F-4110-B8B3-8E82CE4FF9BCQ35660296-F78D794D-DF3C-4AD0-9CDA-A0076E58280FQ35786489-AD7FB5FB-50C9-4137-9C07-00280A2F1914Q36088384-D9A05D00-648F-4070-8A0B-A8373239CE1AQ36327270-C0A7A199-C7C2-403D-AD1A-2BF46FD53B7BQ36575424-2DB72F49-746B-4EEA-9465-F02DB23EC19BQ36671284-0465B986-0B73-46ED-9FD2-7988EE617D80Q36739184-BFF6E59A-AD10-401F-B1F5-C267779BC5B5Q36931223-0942A3D5-76B0-4911-B551-28D028313560Q37044215-9AAF69A2-34E0-47E9-86EA-70DC6F8A86C0Q37096345-DA34553A-A257-4AB4-A001-0B0C355B23F2Q37138023-E7382259-5BB5-4CDA-8E88-0243F0B354BFQ37430285-FDBC5756-36AA-486E-B87D-0D1132AA602DQ37615274-DFD26369-4884-4B61-AAC1-81D592AA218DQ37680323-2F25E0F3-645E-431D-B81F-DC14E041F11BQ37787632-CFF679F2-1C7E-48B0-AF93-51DC745174F5
P2860
Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Polycystic Ovary Syndrome (PCO ...... Significant Morbidity in Women
@ast
Polycystic Ovary Syndrome (PCO ...... Significant Morbidity in Women
@en
type
label
Polycystic Ovary Syndrome (PCO ...... Significant Morbidity in Women
@ast
Polycystic Ovary Syndrome (PCO ...... Significant Morbidity in Women
@en
prefLabel
Polycystic Ovary Syndrome (PCO ...... Significant Morbidity in Women
@ast
Polycystic Ovary Syndrome (PCO ...... Significant Morbidity in Women
@en
P3181
P356
P1476
Polycystic Ovary Syndrome (PCO ...... Significant Morbidity in Women
@en
P2093
E. Carmina
P304
P3181
P356
10.1210/JC.84.6.1897
P407
P577
1999-06-01T00:00:00Z